Fact-checked by Grok 2 weeks ago

Gal4 transcription factor

The Gal4 transcription factor is a zinc-finger protein in the budding yeast Saccharomyces cerevisiae that serves as a master regulator of genes involved in galactose metabolism, binding as a homodimer to specific upstream activating sequences (UASGAL) to recruit transcriptional machinery and activate target gene expression in the presence of galactose. Encoded by the GAL4 gene on chromosome XVI, it consists of 881 amino acids and features a modular structure including an N-terminal DNA-binding domain with a Zn2Cys6 binuclear cluster, a central dimerization region, and two C-terminal acidic activation domains (activation region I [AR I] and AR II) that interact with coactivators like the SAGA and Mediator complexes. This organization allows Gal4 to function as a paradigm for eukaryotic transcriptional activation, where DNA binding is separable from activation, as demonstrated by early deletion analyses. Discovered through genetic studies of galactose utilization mutants in the 1970s and molecularly characterized in the 1980s by Mark Ptashne's laboratory, Gal4 was one of the first factors to be dissected at the structural and functional levels, revealing how acidic activators stimulate transcription without directly contacting . It binds cooperatively to 17-base-pair UASGAL sites (5'-CGG-N11-CCG-3') upstream of genes in the GAL regulon, such as GAL1, GAL2, GAL7, and GAL10, enabling efficient of as a carbon source. In the absence of , Gal4 activity is repressed by the Gal80 protein, which masks the domains; occurs when binds Gal3, relieving this inhibition and allowing Gal4 to drive up to 1,000-fold of target genes. Post-translational modifications, including at serine residues 691, 696, 699, and 837, further fine-tune its potency and interactions. Beyond its native role, Gal4 has become a cornerstone tool in , powering the two-hybrid system for detecting protein-protein interactions and the UAS-GAL4 expression system in model organisms like , where it enables precise, inducible gene misexpression to study development and function. Its conserved activation mechanisms have informed broader principles of eukaryotic gene regulation, including recruitment of chromatin-modifying complexes and the distinction between short and long activation signals.

Discovery and Background

Historical Context

The galactose metabolism pathway in the Saccharomyces cerevisiae has long served as a foundational model for studying inducible in eukaryotes, owing to its tightly controlled response to environmental carbon sources. When is the primary carbon source, yeast induces expression of genes encoding enzymes of the Leloir pathway, which converts to glucose-6-phosphate for . Key genes include GAL1 (encoding galactokinase), GAL7 (), GAL10 (UDP-galactose 4-epimerase), and GAL2 ( permease), clustered or dispersed across the and coordinately regulated to enable efficient metabolism. This system exemplifies by glucose and induction by , providing insights into how eukaryotic cells sense and respond to nutrient availability. Early genetic studies in the laid the groundwork by mapping the structural genes and identifying the need for dedicated regulatory factors to explain their coordinate induction. H.C. Douglas and D.C. Hawthorne isolated mutants defective in galactose utilization, revealing that the pathway enzymes are absent or low in uninduced cells but rapidly synthesized upon galactose exposure, suggesting the involvement of both positive and negative regulators. Their work proposed two unlinked regulatory loci: one promoting induction () and another mediating repression (), based on complementation analysis of non-inducible and constitutive mutants. These findings highlighted the complexity beyond simple operon-like control, as seen in prokaryotes, and underscored the requirement for a diffusible activator to coordinate distant genes. In the , targeted genetic screens for regulatory mutants advanced the Gal4 hypothesis by isolating variants that specifically disrupted induction without affecting enzyme structure. Researchers employed followed by selection on galactose media, identifying recessive gal4 mutants that failed to express pathway enzymes even in inducing conditions, indicating loss of a positive factor. Complementary dominant constitutive mutants mapped to GAL80, reinforcing the dual-control model. These screens, akin to those pioneered by Leland Hartwell for regulators, demonstrated the power of to dissect inducible systems through phenotypic analysis and tests. Such experiments confirmed GAL4 as essential for activation, with mutants showing no basal or induced expression of GAL1, GAL7, GAL10, or GAL2. The role of Gal4 as a positive was initially proposed in 1975 through dosage effect experiments and analysis of cis-acting requirements. Increasing GAL4 copy number via extrachromosomal plasmids led to elevated and partially constitutive enzyme levels, even under repressing conditions, suggesting Gal4 acts as a limiting activator that binds upstream of target genes to facilitate transcription. Mutant complementation further showed that gal4 defects could not be bypassed by high galactose, implying direct interaction with cis-acting promoter elements for induction. This model positioned Gal4 as a paradigm for eukaryotic transcriptional activators, distinct from prokaryotic repressors.

Identification and Characterization

The GAL4 gene was cloned in 1982 by functional complementation of a gal4 null mutant in Saccharomyces cerevisiae using a yeast genomic library constructed in the multicopy plasmid YEp13. This approach isolated the GAL4 locus on a 12-kb DNA fragment, which restored galactose-inducible expression of the GAL genes, confirming its role as a positive regulator of transcription. Northern blot analysis revealed a single 2.8-kb transcript whose abundance was independent of galactose induction, suggesting post-transcriptional regulation of GAL4 activity. In 1984, the complete sequence of the GAL4 gene was determined, identifying an uninterrupted of 2,643 base pairs encoding a protein of 881 with a predicted of 99,350 Da. This characterization established GAL4 as a large, modular protein capable of interacting with DNA and other cellular components to activate transcription of the pathway genes. The protein's expression and activity are regulated by through with the inhibitory protein Gal80, which masks the activation domain in the absence of inducer. Biochemical purification of the GAL4 protein from cell extracts overexpressing the was achieved in 1985 using a multi-step procedure including phosphocellulose ion-exchange chromatography followed by sequence-specific DNA on columns containing the upstream activating (UAS_G). The purified protein, appearing as a 100-kDa polypeptide on , specifically bound to four 17-bp consensus sites (CGGN_{11}CCG) within the UAS_G of the GAL1-GAL10 promoter region, with a in the nanomolar range, as measured by filter-binding and assays. This work provided direct evidence of GAL4's sequence-specific DNA-binding activity.90336-8) Early in vitro transcription assays conducted by 1989 using partially purified yeast nuclear extracts confirmed GAL4's role as a transcriptional activator. Addition of affinity-purified full-length GAL4 or its derivatives to reaction mixtures containing templates with UAS_G sites stimulated RNA polymerase II-mediated transcription up to 20-fold, demonstrating that GAL4 directly recruits the basal transcription machinery without requiring additional yeast-specific factors beyond those in the extract. These experiments delineated the separable DNA-binding and activation functions of GAL4, solidifying its characterization as a prototypical eukaryotic transcriptional activator by the mid-1980s.

Molecular Structure and Domains

DNA-Binding Domain

The (DBD) of the Gal4 transcription factor comprises the N-terminal residues 1–147 and is responsible for sequence-specific recognition of target sites in the promoters of galactose-inducible genes in . This domain includes a conserved Zn₂C₆ binuclear cluster, a fungal-specific finger-like formed by six residues that coordinate two ions in a novel non-intercalating , distinct from classical zinc fingers. The cysteines are arranged in a Cys-X₂-Cys-X₆-Cys-X₆-Cys-X₂-Cys-X₆-Cys , with two cysteines serving as bridging ligands between the zinc ions, stabilizing the compact recognition module essential for interaction. Gal4's DBD binds as a homodimer to the upstream activating UASGAL, a palindromic 17-base-pair defined as 5'-CGG-N11-CCG-3', where N11 represents any spacer of 11 bases. Each monomer of the dimer contacts a conserved CCG triplet at opposite ends of the site, inserting an α-helix from the Zn₂C₆ cluster into the major groove to make specific hydrogen bonds with bases, while the minor groove is contacted by basic residues. The of the minimal DBD (residues 1–65) bound to DNA, solved at 2.7 , demonstrates that dimerization via a short coiled-coil linker enforces the symmetric binding mode and determines the precise spacing between recognition elements. This architecture confers high specificity and affinity, with the full DBD (residues 1–100) exhibiting a dissociation constant (K_d) of approximately 24 nM for cognate UASGAL sites, reflecting cooperative dimerization that enhances stability compared to monomeric fragments. Shorter constructs (residues 1–65) show reduced affinity (>400 nM), underscoring the role of the dimerization domain in optimizing binding. These structural insights from 1990s studies have established Gal4's DBD as a prototype for fungal Zn₂C₆ transcription factors.

Activation Domain

The activation domains of the Gal4 transcription factor are located in two C-terminal regions: activation domain I (ADI), comprising residues 148–196, and activation domain II (ADII), spanning residues 768–881. Both domains are enriched in acidic residues, including aspartic and , conferring a net negative charge that is characteristic of this of transcriptional activators. This acidic composition enables the domains to function modularly when fused to DNA-binding proteins, a property that has been instrumental in dissecting their roles in gene activation. These domains operate via the acidic activation model, in which their negatively charged surfaces and embedded hydrophobic patches facilitate of the transcriptional machinery. Hydrophobic regions within the activation domains bind dynamically to the mediator complex—specifically the Med15 subunit—through a "fuzzy" interface that allows multiple binding orientations and enhances specificity. Additionally, the domains interact with the (TBP), promoting assembly of the pre-initiation complex at promoters. DNA binding by Gal4 is a prerequisite for full potential, as it positions the domains optimally for these protein-protein interactions. Upon DNA binding, Gal4 undergoes conformational changes that boost activation domain efficacy, including a post-association rearrangement with coactivators like Med15 that stabilizes the complex and correlates with transcriptional strength. ADII generally exhibits greater potency than ADI, with particularly robust activity observed in mammalian cells, where it drives significant while ADI shows minimal effect. The acidic motifs in these domains reflect evolutionary conservation, as similar features enable cross-species functionality of Gal4-based systems in organisms ranging from to mammals.

Regulation Mechanisms

Native Regulatory Pathways

The native regulatory pathways of the Gal4 transcription factor in primarily control its activity in response to carbon source availability, enabling efficient metabolism while preventing unnecessary expression under glucose conditions. In the absence of , Gal4 binds to upstream activating sequences (UASGAL) in the promoters of target genes such as GAL1, GAL7, GAL10, and GAL2, but its transcriptional activation is inhibited by the Gal80 protein, which interacts directly with Gal4's activation domain to mask its function and prevent recruitment of the basal transcription machinery. This inhibition maintains low basal expression of the GAL regulon genes. Upon addition of galactose, induction occurs rapidly through a signaling cascade involving Gal3 (and to a lesser extent Gal1, which shares functional similarity). Galactose, along with ATP, binds to Gal3 in the cytoplasm, inducing a conformational change that allows Gal3 to sequester Gal80, thereby relieving its inhibitory binding to Gal4 and permitting Gal4-mediated transcriptional activation of the regulon. This dissociation enables Gal4 to interact with coactivators and the Mediator complex, leading to robust expression of genes required for galactose uptake and conversion to glucose-1-phosphate. The process is highly sensitive, with induction detectable within minutes, underscoring the pathway's role in adaptive metabolism. Glucose exerts strong on the GAL regulon via multiple mechanisms, overriding galactose induction to prioritize glucose utilization. The zinc-finger Mig1 binds to specific sites in the GAL4 promoter, reducing Gal4 protein levels by approximately fourfold and thereby limiting activation potential; this repression is relieved by the Snf1 kinase complex under low-glucose conditions, which phosphorylates and inactivates Mig1. Additionally, Mig1 can bind UAS elements in target gene promoters like GAL1, contributing to direct repression, while other components such as 2 (Hxk2) and the Reg1-Glc7 phosphatase complex enhance this effect by modulating Snf1 activity. These layers ensure near-complete shutdown of the pathway in glucose media, with GAL1 expression repressed up to 1000-fold compared to galactose-grown cells. Feedback loops fine-tune Gal4 activity to match metabolic needs and prevent overactivation. The GAL4 promoter contains UASGAL sites that allow autoregulation, whereby activated Gal4 binds its own promoter to amplify expression during sustained exposure, creating a that sustains regulon output. Post-translationally, inactive Gal4 (bound to Gal80) is targeted for ubiquitin-mediated degradation by the F-box protein Grr1 in a glucose-dependent manner, while active Gal4 is turned over by Dsg1 (also known as Mdm30) to limit accumulation and allow rapid response to changing conditions. This dynamic , including Gal80's own by Gal4, forms an that balances induction strength and pathway fidelity.

Engineered Variants and Mutants

Engineered variants of the Gal4 transcription factor have been developed to dissect its functional domains and enable conditional control in experimental systems. The classic null , gal4Δ, results from deletion of the C-terminal activation domain, producing a protein that retains DNA-binding capability but fails to activate transcription, thereby preventing inducible growth on media. Complete deletion of the similarly abolishes -inducible , confirming its essential role in the pathway. Temperature-sensitive alleles, such as gal4ts, were engineered by of buried hydrophobic residues (e.g., F68R, L70P) in the protein core, allowing normal function at permissive temperatures (21–30°C) but rapid inactivation at restrictive temperatures (37°C), facilitating temporal studies of Gal4 activity. Inactive constructs have been crucial for isolating domain-specific functions. DNA-binding defective mutants, including missense alterations in the zinc-binding cysteines of the (e.g., C21 and C38 mutations), abolish sequence-specific binding to UAS sites without affecting potential when fused to other domains. Activation-defective variants, such as those with deletions of the acidic regions (e.g., removal of residues 148–196 or 768–881), eliminate transcriptional stimulation while preserving DNA binding and nuclear localization. Fusion proteins extend Gal4's utility across systems. The Gal4-VP16 chimera, combining the Gal4 (residues 1–147) with the potent VP16 activation domain from , exhibits unusually strong transcriptional in mammalian cells, even at distant promoter sites, surpassing native Gal4 efficacy. Gal4-LexA chimeras, fusing the Gal4 domain to the bacterial LexA , enable targeted in strains with LexA operators, bypassing native UAS elements for modular control. Post-2010 developments include optically inducible variants for optogenetic applications. The ShineGal4 system, a split-Gal4 variant incorporating Magnet photoreceptor domains (nMagHigh1 and pMagHigh1), allows blue-light (491 nm)-induced heterodimerization and rapid UAS-driven expression in tissues, achieving half-maximal activation within ~5 hours and spatial precision via two-photon illumination. Similarly, photoactivatable Gal4 constructs using LOV domains enable light-dependent nuclear translocation and transcription in mammalian cells, with optimized variants showing minimal dark-state activity and fold-induction up to 100-fold upon illumination.

Function and Mechanism

Interaction with Target Genes

The Gal4 transcription factor locates its target genes in the genome by binding to specific upstream activating sequence (UASGAL) elements, which consist of a 17-base pair (CGG(N)11CCG) typically found in the promoter regions of galactose-inducible genes. These UASGAL sites are present in multiple copies upstream of key GAL genes to enhance binding affinity and transcriptional synergy; for instance, the bidirectional GAL1-GAL10 promoter contains four such sites, enabling cooperative DNA binding by Gal4 dimers. This multimeric binding stabilizes Gal4 association with , particularly under galactose induction when Gal4 is relieved from Gal80 repression. In the context of yeast chromatin, where DNA is packaged into nucleosomes that can occlude binding sites, Gal4 facilitates access to its targets by recruiting the SWI/SNF chromatin remodeling complex via interactions between its activation domain and SWI/SNF subunits. This recruitment promotes ATP-dependent nucleosome displacement and repositioning at UASGAL sites, thereby exposing the DNA for stable Gal4 binding and subsequent regulatory events; studies in swi/snf mutants demonstrate severely impaired Gal4 occupancy and GAL gene induction, underscoring the essential role of this remodeling in target gene accessibility. The UASGAL elements function as transcriptional enhancers, activating target promoters in a manner independent of their precise position or orientation relative to the transcription start site, provided they are located upstream within approximately 1 kb. This flexibility was demonstrated in early functional assays where UASGAL fragments inserted at various upstream locations or in inverted orientations retained their ability to drive galactose-inducible expression of reporter genes, distinguishing them from rigid core promoter elements. Activation efficiency diminishes beyond 1 kb due to constraints and dependencies, limiting long-range effects compared to metazoan enhancers. Genome-wide (ChIP) studies, including ChIP-chip analyses from the early 2000s, have revealed that Gal4 binds to UASGAL-like sites at approximately 40 loci beyond the core (GAL1, GAL2, GAL7, GAL10), with potential binding motifs distributed across promoters, open reading frames, and intergenic regions. However, under standard induction conditions, functional regulation is largely confined to the ~10-15 primary GAL targets, while off-cluster sites may represent latent or context-dependent interactions identified through high-affinity binding in overexpression or mutant backgrounds. These findings highlight Gal4's specificity for UASGAL motifs while suggesting broader scanning capabilities .

Transcriptional Activation Process

The transcriptional activation process of Gal4 begins with the recruitment model, wherein the activation domain (AD) of Gal4, bound to upstream activating sequence (UAS) elements, directly interacts with components of the basal transcription machinery to facilitate pre-initiation complex () assembly at the promoter. Specifically, the Gal4 AD contacts (TBP), a subunit of TFIID, thereby stabilizing TBP's association with the and promoting the recruitment of additional general transcription factors () such as TFIIA and TFIIB. Furthermore, the Gal4 AD engages the Mediator complex, a multi-subunit coactivator that bridges the activator to (Pol II) and the , enhancing the stability and efficiency of PIC formation at the core promoter. This recruitment mechanism, first elucidated through genetic and biochemical studies in , underscores how Gal4 overcomes the low basal affinity of the transcription machinery for promoters lacking activators. In addition to direct recruitment, Gal4 promotes enhancer-promoter looping, enabling physical proximity between distally bound Gal4 multimers at UAS sites and the target promoter, which further stabilizes interactions with the transcription apparatus. Gal4 dimers bound to multiple UAS elements can oligomerize, facilitating DNA bending or looping that brings the enhancer into close contact with the promoter, as demonstrated by chromatin immunoprecipitation and electron microscopy assays in yeast cells. This looping is particularly evident in the GAL1-GAL10 locus, where Gal4 multimers induce stable enhancer-promoter contacts essential for robust activation. The process exhibits rapid upon , with transcription occurring within minutes of Gal4 derepression, reflecting the of recruitment and looping. In , addition of triggers Gal4-mediated transcription of target genes like GAL1 within 4 minutes, highlighting the near-immediate stabilization of the . arises from multiple UAS sites, where of Gal4 multimers amplifies activation; for instance, four tandem UAS elements can yield up to 100-fold higher transcription compared to a single site, due to enhanced recruitment of coactivators and Pol II. In vitro reconstitution assays have confirmed these mechanisms, demonstrating that purified Gal4 AD can stimulate transcription 10- to 100-fold over basal levels in nuclear extracts or purified systems containing Pol II, , and . These experiments, using templates with UAS-bound Gal4 derivatives, show that activation requires direct AD contacts with TBP and , without , and scale with the number of UAS sites to mimic .

Role in Protein Degradation

The Gal4 transcription factor undergoes ubiquitin-dependent degradation by the 26S proteasome as a critical regulatory mechanism to modulate its transcriptional activity. Ubiquitination signals embedded within its second activation domain (ADII) serve as recognition elements that target activated Gal4 for proteasomal turnover, ensuring that the protein does not persist excessively at target promoters. This process is mediated by the F-box protein Dsg1/Mdm30, which facilitates polyubiquitination specifically in the transcriptionally active form of Gal4. Upon by , Gal4 transitions to its active conformation (Gal4c), triggering rapid degradation with a of less than 5 minutes. This activation-induced cycle limits prolonged target , generating transient pulses of transcriptional activation that are essential for fine-tuned regulation of the GAL network. In the absence of , Gal4 exhibits a longer of approximately 20 minutes, highlighting the stimulus-dependent nature of its turnover. The functional significance of this lies in preventing cellular from constitutive Gal4 activity, which could otherwise lead to aberrant and disrupt metabolic . By coupling to activation, the system promotes efficient mRNA processing and elongation while avoiding accumulation of stalled transcription complexes. Gal4's turnover is further intertwined with interactions involving the coactivator complex, where components like Spt3 influence the formation of the active Gal4c isoform prior to its . Seminal studies from the in the Ptashne laboratory established the modular architecture of Gal4, including its domains, and demonstrated how post-translational modifications like initiate its activity; subsequent research built on this foundation to show that proteasome-mediated degradation enhances these transient pulses for optimal gene control.

Applications in

Yeast Two-Hybrid Screening

The yeast two-hybrid (Y2H) system, developed in 1989 by Stanley Fields and Ok-Kyu Song, exploits the modular structure of the Gal4 transcription factor to detect protein-protein interactions in vivo. By separating Gal4 into its (DBD) and activation domain (AD), the system allows these domains to be fused to proteins of interest, reconstituting transcriptional activity only upon interaction between the fused partners. This innovation enabled the first genetic assay for direct protein-protein contacts, initially tested with the interacting yeast proteins SNF1 and SNF4. In the standard Y2H mechanism, the bait protein is fused to the Gal4 DBD and expressed in reporter strains harboring Gal4-responsive promoters upstream of selectable markers like HIS3 (for prototrophy) or LACZ (for colorimetric detection via ). The prey protein, fused to the Gal4 AD, is introduced via a or specific construct; brings the DBD and AD into proximity, recruiting to activate expression and produce a detectable , such as growth on selective media. This reconstitution principle relies on the functional independence of Gal4 domains, allowing high-fidelity detection of binary interactions in the nucleus. The Y2H system's primary advantages include its high-throughput nature, facilitating screening of large cDNA libraries to map interactomes, and its genetic simplicity, which integrates selection and cloning in a single eukaryotic host. However, limitations arise from false positives caused by non-specific transcriptional activation by AD fusions or auto-activation of baits, as well as false negatives due to incompatibilities like membrane-bound or post-translationally modified proteins not folding correctly in . These issues have prompted optimizations, such as normalized libraries and counterscreens, to enhance specificity. Subsequent evolution includes the reverse Y2H system, introduced in 1996, which inverts the logic to select against interactions by linking Gal4 reconstitution to a counterselectable marker like CYH2 ( sensitivity), enabling identification of disruptive mutations or inhibitory compounds. This variant has expanded applications to and . Overall, the Y2H system, grounded in Gal4 , has been cited in over 10,000 publications and remains a for studies into the 2020s.

Gene Expression Systems and Synthetic Biology

The GAL4-UAS system serves as a foundational tool for tunable gene expression in yeast, where GAL4 binds to upstream activating sequences (UAS) to drive transcription of target genes upon galactose induction, enabling precise control over expression levels for metabolic pathway optimization. This binary architecture separates the regulator (GAL4 under a constitutive or inducible promoter) from UAS-linked effectors, allowing modular vector design for high-level, inducible expression without native regulatory interference. In Saccharomyces cerevisiae, UAS-driven vectors have been widely adopted for engineering complex pathways, with expression folds exceeding 1000-fold upon induction, facilitating rapid prototyping of synthetic constructs. Adaptations of the GAL4-UAS system to mammalian cells involve fusions like GAL4-VP16, where the VP16 activation domain enhances transcriptional potency in heterologous contexts, achieving up to 100-fold induction of UAS reporters in cell lines such as NIH 3T3. This chimeric activator binds UAS elements upstream of minimal promoters, providing an orthogonal control mechanism to endogenous mammalian factors, and has been integrated into viral vectors for stable, inducible expression . In , optogenetic variants such as photoactivatable GAL4 (Opto-GAL4) emerged in the to enable light-inducible circuits, with triggering dimerization and UAS activation for spatiotemporal precision in and mammalian systems. For instance, Vivid-based Opto-GAL4 achieves activation with peak expression within ~1.5 hours of exposure and fold-inductions up to 50-fold, supporting dynamic circuit design without chemical inducers. Similarly, CRISPR-GAL4 fusions, such as dCas9-VP64-GAL4, allow targeted activation by guiding catalytically inactive to promoters via sgRNAs, recruiting GAL4 for UAS-mediated enhancement and improving expression at endogenous loci. Applications of GAL4-UAS extend to , where inducible overexpression of biosynthetic genes in has enhanced production; for example, optimized GAL4 systems increased production by up to 9-fold in engineered S. cerevisiae strains. In , the system facilitates disease modeling by driving UAS-linked in specific tissues, recapitulating pathologies like neurodegeneration with temporal control. As of 2025, advances include GAL4-based feed-forward loop circuits that boost transgene expression in such as . Recent developments also feature intein-mediated GAL4 variants for temperature-inducible pathways in .

References

  1. [1]
    GAL4 | SGD - Saccharomyces Genome Database
    Dec 1, 2010 · GAL4 encodes a transcription factor that is the archetypal member of ... Ma J and Ptashne M (1987) Deletion analysis of GAL4 defines two ...
  2. [2]
    Yeast Gal4: a transcriptional paradigm revisited - PMC - NIH
    During the past two decades, the yeast Gal4 protein has been used as a model for studying transcriptional activation in eukaryotes.
  3. [3]
    Separation of DNA Binding from the Transcription-Activating ...
    The yeast GAL4 protein (881 amino acids) binds to specific DNA sites upstream of target genes and activates transcription. Derivatives of this protein ...
  4. [4]
    Yeast Gal4: a transcriptional paradigm revisited | EMBO reports
    ### Summary of Gal4: History, Structure, Mechanism, and Role as a Model System
  5. [5]
    Structure of the DNA-binding domain of zinc GAL4 - Nature
    Apr 2, 1992 · THE yeast transcriptional activator GAL4 binds co-operatively to four related 17-base-pair sequences within an upstream activating sequence ...
  6. [6]
    The GAL4 system : a versatile system for the expression of genes
    Here we describe the GAL4 system highlighting the properties that make it a powerful tool for the analysis of gene function in Drosophila and higher organisms.
  7. [7]
    GAL Regulon in the Yeast S. cerevisiae is Highly Evolvable via ...
    Mar 13, 2022 · GAL network in the yeast S. cerevisiae is one of the most well-characterized regulatory network. Expression of GAL genes is contingent on exposure to galactose.Abstract · Introduction · Results · Discussion and Conclusion
  8. [8]
    Studies on the positive regulatory gene, GAL4, in regulation of ...
    Sep 1, 1975 · Studies were undertaken to elucidate the role of the GAL4 locus in regulating the galactose catabolic enzymes in Saccharomyces cerevisiae.
  9. [9]
  10. [10]
    DNA recognition by GAL4: structure of a protein-DNA complex - Nature
    Apr 2, 1992 · The protein binds as a dimer to a symmetrical 17-base-pair sequence. A small, Zn2+-containing domain recognizes a conserved CCG triplet at each ...
  11. [11]
    DNA recognition by GAL4: structure of a protein-DNA complex
    Apr 2, 1992 · The protein binds as a dimer to a symmetrical 17-base-pair sequence. A small, Zn(2+)-containing domain recognizes a conserved CCG triplet at ...
  12. [12]
    Structural Basis for Dimerization in DNA Recognition by Gal4 - PMC
    Gal4 was one of the earliest eukaryotic DNA-binding transcription factors that were characterized and analyzed at the cellular and molecular level and has thus ...Missing: original | Show results with:original
  13. [13]
    Mediator subunit Med15 dictates the conserved “fuzzy” binding ...
    Apr 13, 2021 · Gal4 consists of an N-terminal DNA-binding domain that targets the upstream activating sequence of Gal4-regulated genes, a large central domain ...
  14. [14]
    Targets of the Gal4 Transcription Activator in Functional ...
    Yeast Gal4, one of the first known acidic activators, is responsible for the regulation of genes involved in galactose catabolism (41). In the absence of ...<|control11|><|separator|>
  15. [15]
  16. [16]
    structure and interactions of the GAL4 dimerization domain - NIH
    The GAL4 dimerization domain (GAL4-dd) is a powerful transcriptional activator when tethered to DNA in a cell bearing a mutant of the GAL11 protein, ...Missing: ADI ADII<|control11|><|separator|>
  17. [17]
    Targeted gene expression by the Gal4‐UAS system in zebrafish
    Jul 4, 2008 · Targeted gene expression by the Gal4-UAS system is a powerful methodology for analyzing function of genes and cells in vivo and has been extensively used in ...Introduction · The Gal4-UAS system: before... · Modifications of activities of...
  18. [18]
    Commonly asked questions about transcriptional activation domains
    Dec 5, 2023 · Acidic activation domain function is deeply conserved across eukaryotes. The Gal4/UAS system from yeast works beautifully in flies, mammals ...
  19. [19]
  20. [20]
  21. [21]
    Design of temperature-sensitive mutants solely from amino acid ...
    Such Ts mutants of Gal4 can be used for conditional expression of a variety of genes by using the well characterized upstream-activating-sequence–Gal4 system.
  22. [22]
    Mutations that alter both localization and production of a yeast ...
    GAL4 mutated at amino acids cysteine 21, cysteine. 38, arginine 51, and ... The GAL4 DNA-binding domain is also con tained in the first 74 amino acids ...
  23. [23]
    GAL4-VP16 is an unusually potent transcriptional activator - Nature
    Oct 6, 1988 · We show that the hybrid protein (GAL4-VP16) activates transcription unusually efficiently in mammalian cells when bound close to, or at large distances from ...
  24. [24]
    Analysis of Gal4-directed transcription activation using Tra1 ... - PNAS
    Here we perform a large-scale genetic screen to derive and characterize tra1 alleles that are selectively defective for interaction with Gal4 in vivo.Missing: original | Show results with:original
  25. [25]
    Rapid and robust optogenetic control of gene expression in ...
    Dec 7, 2021 · Here, we report the development of a light-inducible split-Gal4 that provides rapid and robust gene expression control in space and time in ...
  26. [26]
    Promoter Architecture and Promoter Engineering in Saccharomyces ...
    The promoters PGAL1, PGAL2 and PGAL10 contain four UASGAL sites, while PGAL7 only has one. During the induction of galactose, the production of Gal4p can ...2. Promoter Architecture And... · 2.1. Core Promoters · 2.3. Nucleosomes Disfavoring...
  27. [27]
    Recruitment of the SWI/SNF chromatin remodeling complex by ... - NIH
    Here we demonstrate that SWI/SNF can be recruited from yeast nuclear extracts by a transcriptional activator. Recruitment is dependent on an activation domain ...Missing: source | Show results with:source
  28. [28]
    SWI-SNF Complex Participation in Transcriptional Activation at ... - NIH
    We show that the ability of the transcriptional activator GAL4 to bind to a site in a positioned nucleosome is not appreciably impaired in swi mutant yeast ...Missing: source | Show results with:source
  29. [29]
    Analysis of Transcriptional Activation at a Distance in ... - NIH
    Transcription of the HS2 enhancer toward a cis-linked gene is independent of the orientation, position, and distance of the enhancer relative to the gene.
  30. [30]
    Science | AAAS
    - **Insufficient relevant content**: The provided URL (https://www.science.org/doi/10.1126/science.290.5494.2306) leads to a "Page not found" error, indicating the page is inaccessible or does not exist.
  31. [31]
    Comprehensive Genome-wide Protein-DNA Interactions Detected at ...
    Transcription factor Gal4 reportedly binds to and regulates only ten genes related to the yeast galactose regulon (Ren et al., 2000). We identified 15 Gal4 peak ...
  32. [32]
    Are All DNA Binding and Transcription Regulation by an Activator ...
    The Gal4 binding sites in GAL1-10 are also listed. The sequences matching the consensus UASGAL are in boldface type. The fraction listed is the total number of ...
  33. [33]
    An Activator Target in the RNA Polymerase II Holoenzyme
    ... GAL4 may recruit the entire transcription apparatus to promoters. GAL4 could act by recruiting TBP and then the holoenzyme to a promoter. However, at the ...
  34. [34]
    Yeast Gal4: a transcriptional paradigm revisited | EMBO reports
    Pioneering studies on Gal4 from the Ptashne laboratory shaped our conceptual understanding of transcriptional activation in eukaryotes (reviewed in Ptashne & ...
  35. [35]
    DNA looping induced by a transcriptional enhancer in vivo - NIH
    Yeast enhancers, which are called upstream activating sequences (UASs) are less flexible in terms of distance and position relative to the regulated promoter ...
  36. [36]
    Rapid GAL Gene Switch of Saccharomyces cerevisiae Depends on ...
    By 4 min after galactose addition, Gal4-activated gene transcription ensues. It is well established that this rapid induction arises through a galactose- ...Missing: onset | Show results with:onset
  37. [37]
    A mechanism for synergistic activation of a mammalian gene by ...
    May 24, 1990 · In this paper we show that synergistic activation by each of several GAL4 derivatives involves a mechanism different from that illustrated by the lambda ...Missing: isolation 1982
  38. [38]
  39. [39]
    The F Box Protein Dsg1/Mdm30 Is a Transcriptional Coactivator that ...
    Destruction of transcriptionally active Gal4 depends on an F box protein called Dsg1/Mdm30. In the absence of Dsg1, Gal4 is stable, nonubiquitylated, and ...Results · The F Box Protein Grr1... · The F Box Protein Dsg1 Is...
  40. [40]
    An Unexpected Role for Ubiquitylation of a Transcriptional Activator
    ... protein ubiquitylation and degradation can be uncoupled. Modification of the Gal4 transcription activation domain by Dsg1/Mdm30-mediated ubiquitylation ...
  41. [41]
  42. [42]
    A novel genetic system to detect protein–protein interactions - Nature
    Jul 20, 1989 · We have generated a novel genetic system to study these interactions by taking advantage of the properties of the GAL4 protein of the yeast Saccharomyces ...
  43. [43]
    A novel genetic system to detect protein-protein interactions - PubMed
    Jul 20, 1989 · We have generated a system of two hybrid ... We have tested this system using two yeast proteins that are known to interact--SNF1 and SNF4.
  44. [44]
    Yeast Two-Hybrid, a Powerful Tool for Systems Biology - PMC
    Jun 18, 2009 · This review provides an overview on available yeast two-hybrid methods, in particular focusing on more recent approaches.
  45. [45]
    Two Hybrid Screening: Advantages and Disadvantages
    The yeast two-hybrid system is popular due to its flexibility and rapid isolation of interacting proteins; the major drawback is its limited applicability.
  46. [46]
    Improving yeast two-hybrid screening systems - Oxford Academic
    Jan 24, 2008 · In this review, we discuss and compare different approaches for adaptation of Y2H screening to high-throughput, the limits of the method and possible ...HOW THE Y2H SYSTEM... · ARRAYS OF PREYS · LIMITATIONS OF THE Y2H...
  47. [47]
    Reverse Two-Hybrid System: A Genetic Scheme for Selection ...
    ( B ) The reverse Gal4 two-hybrid system is a genetic selection scheme that selects against the association of c-Rel fused to the DNA-binding domain of Gal4 ...
  48. [48]
    The yeast two-hybrid system for identifying protein-protein interactions
    Aug 5, 2025 · The yeast two-hybrid assay is a system for identifying and analysing protein-protein interactions. Since the original description in 1989, ...
  49. [49]
    The synthetic biology toolbox for tuning gene expression in yeast
    This review provides an update on the status of the synthetic biology toolbox in yeast for use as a cell factory.Plasmid Selection · Promoters · Multigene Expression...<|control11|><|separator|>
  50. [50]
    Engineering an Efficient Expression Using Heterologous GAL ...
    May 24, 2023 · The Gal4 transcription factor (TF) controls gene expression by binding the DNA sequence motif CGG(N11)CCG. Well studied versions regulate ...Figure 2 · Gal4p Overexpression... · Figure 3
  51. [51]
    GAL4-VP16 is an unusually potent transcriptional activator - PubMed
    We show that the hybrid protein (GAL4-VP16) activates transcription unusually efficiently in mammalian cells when bound close to, or at large distances from ...
  52. [52]
    A selective transcriptional induction system for mammalian cells ...
    Most mammalian cells neither express any Gal4-like activity nor endogenous estrogen receptor, thus rendering estrogen an inert signal for them.
  53. [53]
    Enhancement of Vivid-based photo-activatable Gal4 transcription ...
    Abstract. The Gal4/UAS system is a versatile tool to manipulate exogenous gene expression of cells spatially and temporally in many model organisms.Missing: paper | Show results with:paper
  54. [54]
    Gene activation by a CRISPR-assisted trans enhancer - eLife
    Apr 11, 2019 · In this strategy, CMV enhancer DNA was recruited to target genes in trans by two systems: dCas9-VP64/csgRNA-sCMV and dCas9-VP64-GAL4/sgRNA-UAS- ...
  55. [55]
    Design of Multipartite Transcription Factors for Multiplexed Logic ...
    Oct 14, 2020 · Gal4 binds to its cognate response element (UAS) and drives the expression of an mCherry-P2A-SEAP reporter gene with an ribozyme (HHR) in the 3′ ...